Disease Information for Efalizumab (Raptiva) Administration/Toxicity

Ads
Associated Diseases & Rule outs
Associated Disease & Complications
Progressive leukoencephalopathy/multifocal
Disease Mechanism & Classification
Drugs
DRUG/ Source rDNA Manufacture
DRUG/Anti CD11a Lymphocyte Antibody
DRUG/Anti-inflammatory drug (example)
DRUG/Anti-Psoriasis medication (ex)
DRUG/DNA Bioengineered Antibody (Imab/Umab/Omab)
DRUG/Genetically engineered/biological drug (example)
DRUG/Immune modulator drug (ex)
DRUG/Immune suppressant drug (example)
DRUG/Monoclonal antibody medication/mab (example)
DRUG/Monoclonal Derived Antibody
DRUG/Monoclonal Derived Umab Type
DRUG/New release 2008
DRUG/Specialized usage (example)
DRUG-New drugs (listed only)
Process
PROCESS/Medication/Drug (CONFIRM dose/before treatment)
Synonyms
Synonym
administration, Efalizumab (Raptiva), Brand name/Raptiva (Efalizumab)
Treatment
Drug Dosage
DRUG/Dose Weekly
DRUG/Drug discontinued/TOXIC (RX)
DRUG/Injectable medication (parenteral)
DRUG/Subcutaneous administration medication
DRUG/Twelve week course usual
Definition

Immuno-suppressive monoclonal antibody; parenteral preparation; Anti-cytokine drug binds leukocyte CD11a alpha unit of LFA-1 [intercellular adhesion receptor]; used for psoriasis severe plaque type

(Edit)

External Links Related to Efalizumab (Raptiva) Administration/Toxicity
Google
Wikipedia
Merck
Images
PubMed (National Library of Medicine)
NGC (National Guideline Clearinghouse)
Medscape (eMedicine)
Harrison's Online (accessmedicine)
NEJM (The New England Journal of Medicine)
Ads